The Wellington Hospital’s Liver Unit provides the best available treatment for conditions that affect the liver, pancreas and biliary tree, supported by up-to-date and comprehensive imaging and surgical facilities.
Core to the consultant team are Professor Brian Davidson, Dr Ameet Dhar, Mr Giuseppe Fusai, Dr James O'Beirne, and Dr David Patch.
Each is an expert in his field. Professor Davidson is Professor of Surgery at the Royal Free Hospital in London. He has a particular interest in liver, biliary tract and pancreatic surgery, with an emphasis on the management of cancer. He also has one of the largest practices in the UK for surgical reconstruction following laparoscopic bile duct injury.
Dr Ameet Dhar specialises in gastroenterology, with a key interest in hepatology. He is widely published, with over a dozen articles to his name. Dr Dhar practices at Charing Cross Hospital, Hammersmith Hospital, and St Mary's Hospital in London.
Mr Giuseppe Fusai began his surgical training in Italy. In 1992 he attained Master of Surgery accreditation from the University of Parma, then in 2005 took up the position of hepato-pancreato-biliary (HPB) consultant surgeon. His primary clinical and academic interests are in liver metastases, hilar cholangiocarcinoma and pancreatic cancer, and in the treatment of patients with advanced disease including vascular reconstruction. He has authored over 50 research articles.
Dr James O'Beirne is a Consultant Hepatologist. With a base at The Royal Free, he shares in the care of their liver transplant patients, as well as the management of patients witha cute and chronic liver disease. He has an interest in the intensive care of liver patients, and research interests in acute liver failure, variceal bleeding and transplantation.
Dr David Patch is Consultant Physician and Honorary Senior Lecturer at the Royal Free Hospital, and fundamental to its liver transplant service. As a leading expert in trans-jugular liver biopsies, he also maintains a broad Endoscopic practice. Dr Patch is involved with clinical trials and research into portal Hypertension.
Together, the team provides best-in-class care for all HPB treatment.
Services provided to HCA
This group of doctors provide medical advisory services for HCA's The Wellington Hospital. In their role, they lead interactions with hospital medical staff and the hospital leadership team to assist the hospital by providing medical advice and promote high quality, cost effective care.
In their role, they contribute to the strategy, policies and decision making regarding liver treatments and advise HCA to ensure that care provided within the facility is appropriate and efficient. In their role, they advise on initiatives to drive clinical standards by providing professional advice on clinical governance matters and ensuring the adoption of those by colleagues in treatment of diseases of the liver.
In addition, they work with medical insurance companies, GPs, other relevant local NHS contacts, and patients to educate and advise on relevant clinical updates available in the facility.
In conjunction with the Liver Unit The Wellington was one of the first hospitals in the country to introduce a new drug therapy for chronic hepatitis C infections. The unit is currently advising on the feasibility of the hospital providing Selective internal radiation therapy at the hospital, which is a form of radiation therapy used in interventional radiology to treat cancer that are generally unresectable.
Furthermore, they advise on the accuracy of literature that may be published regarding relevant services. They will also advise on how to make the patient referral smooth to reduce stress and anxiety for patients.
HCA UK is charged by doctors in return for their expertise and advice, including on how to operate safe hospital facilities delivering complex care.
All services provided under this agreement are charged to HCA UK. From January to December 2017, the total charge was £22,174.
HCA requires the doctors that advise us to attest that if they also practice in the NHS that they are not compromising their NHS commitments.
The information disclosed on this page in accordance with the Private Healthcare Market Investigation Order 2014 is true and accurate to the best of HCA’s knowledge and belief.